Here are relevant reports on : eTMF-market
-
Electronic Trial Master File (eTMF) Systems Market by Offering (Integrated, Standalone), Function (Analytic, Compliance, Workflow, Audit), Therapeutic (Onco, Cardio, Neuro), End User (Pharma, Biotech, MedDevice), Phase, Region - Global Forecast to 2030
The global electronic trial master file (eTMF) systems market, valued at US$1.21 billion in 2024, stood at US$1.36 billion in 2025 and is projected to advance at a resilient CAGR of 12.8% from 2024 to 2030, culminating in a forecasted valuation of US$2.49 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Europe eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Opportunities, Trends, Market Share - Forecast to 2030
The Europe eClinical solutions market, valued at US$2.82 billion in 2024, stood at US$3.18 billion in 2025 and is projected to advance at a resilient CAGR of 13.0% from 2025 to 2030, culminating in a forecasted valuation of US$5.86 billion by the end of the period. This growth is driven by the increasing shift toward digital and decentralized clinical trial models enabled by CTR and CTIS adoption.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (CRO, Pharma, Biotech, Medtech) Regulatory, Al, Growth, Market Size - Forecast to 2030
US eClinical solutions market, valued at US$5.26 billion in 2024, stood at US$5.99 billion in 2025 and is projected to advance at a resilient CAGR of 14.2% from 2025 to 2030, culminating in a forecasted valuation of US$11.64 billion by the end of the period. The growth is driven by the rising number of clinical trials conducted across major research hubs, particularly in oncology, immunology, and rare diseases.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Operation, Analytics), Trial Phase, End User (Pharma, Biotech, Medtech), Trends, Growth, Market Insight - Forecast to 2030
The Asia Pacific eClinical solutions market, valued at US$2.08 billion in 2024, stood at US$2.39 billion in 2025 and is projected to advance at a resilient CAGR of 15.4% from 2024 to 2030, culminating in a forecasted valuation of US$4.88 billion by the end of the period. The Asia Pacific eClinical solutions market is experiencing rapid growth, driven by increasing clinical trial activity, expanding digital infrastructure, and the rising adoption of advanced technologies across the region’s research ecosystem.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, RTSM, eTMF, RIMS, eConsent), Application (Collection, Analytics), Phase, Trial (Decentralized), Therapy (Onco, Cardio, Neuro, Rare Disease), End User (CRO, Pharma & Biotech) - Forecast to 2031
The global eClinical solutions market is projected to reach USD 31.32 billion by 2031, growing at a CAGR of 14.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Clinical Laboratory Services Market by Specialty (Biochemistry, Endocrinology, Microbiology, Hematology, Cytology, Histopathology, Genetic Testing), Providers (Independent Laboratory, Reference Laboratory, Hospital Laboratory) & Geography - Global Forecast to 2022
The clinical laboratory services market is expected to reach USD 146.41 billion by 2022 from USD 113.4 billion in 2017, at a CAGR of 5.2% during the forecast period. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Holdings (US), Quest Diagnostics Incorporated (US), Spectra Laboratories Inc. (US), DaVita Healthcare Partners (US), Eurofins Scientific (Luxembourg), Unilabs (Switzerland), SYNLAB International (Germany), Bio-Reference Laboratories (US), Sonic Healthcare (UK), Cerba HealthCare (France), and among others
- Published: December 2017
- Price: $ 4950
- TOC Available:
-
Outlook of Cardiac Pacemaker Market - Global Forecasts (2011-2016)
Pacemaker devices constitute a major segment in a rapidly expanding cardiovascular devices market. The global cardiac pacemakers market is characterized by relatively mature conditions and intense competition. However, an aging global population, and the subsequent rise in the incidence of cardiovascular diseases, has ensured a steady growth for the pacemakers market.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Erectile Dysfunction, Premature Ejaculation & Alopecia Market - Global Forecasts (2011-2016)
The development of erectile dysfunction is associated with an underlying cause which is organic in nature. Drug induced causes of erectile dysfunction are common and can complicate the medical management of underlying conditions such as hypertension, depression, and BPH. Beta blockers, selective serotonin reuptake inhibitors (SSRIs), and the uroselective alpha adrenergic receptor antagonists have been associated with the loss of libido or ejaculatory disorders, which can result in drug discontinuation by patients and suboptimal treatment of these conditions.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Consumables [Media, Sera, Reagents (Supplements, Buffers)], Vessels (Plates, Flask, Roller Bottle), Equipment (Bioreactor, Filtration, Incubators, Centrifuge), Application (mAbs, Vaccines, CGT), Competition - Global Forecast to 2031
The global cell culture market is projected to reach USD 58.42 billion by 2031, growing at a CAGR of 12.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: December 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
